The World Health Organisation (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for the treatment of type 2 diabetes and obesity in some countries.
Trending
- Nigeria fully digitized 38 MDAs, says civil service head
- NCS urges better use of community sports facilities in Apapa
- Nigeria launches N50m fund for cancer patients
- Nigeria’s current account surplus jumps 256% to $4.98bn in Q1 2026
- IWMI, IFPRI link Kano farmers to solar irrigation support
- NCS urges border officers to prioritize safety
- Keke riders protest police harassment in Warri
- NEDC boosts healthcare in Adamawa
